Captrust Financial Advisors »

Zentalis Pharmaceuticals shares owned by Captrust Financial Advisors

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Captrust Financial Advisors from 13F filings

Historical chart of Captrust Financial Advisors investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Captrust Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Captrust Financial Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $16k 11k 1.51
2025-06-30 $14k 12k 1.16
2025-03-31 $25k 16k 1.59
2024-12-31 $33k 11k 3.03
2022-06-30 $21k 750 28.00
2022-03-31 $35k 763 45.87
2021-12-31 $0 5 0.00
2020-12-31 $20k 385 51.95

More positions owned by Captrust Financial Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Apple Stock (AAPL)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Microsoft Corp Stock (MSFT)
Vanguard Value Etf (VTV)
Nvidia Corporation Stock (NVDA)
Vanguard S&p 500 Etf Etf (VOO)
Vanguard Growth Etf Etf (VUG)
Ishares Core Msci Total International Stock Etf Etf (IXUS)
Ishares 3-7 Year Treasury Bond Etf Etf (IEI)
Vanguard Mega Cap Growth Etf Etf (MGK)
Vanguard Small-cap Etf Etf (VB)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Ishares Core Msci Emerging Market Etf Etf (IEMG)

View all positions for Captrust Financial Advisors

Top funds holding Zentalis Pharmaceuticals

Matrix Capital Management Company
Vanguard Group
Acadian Asset Management
Renaissance Technologies
Citadel Advisors
Tang Capital Management
Two Sigma Advisers
D. E. Shaw & Co
Two Sigma Investments
Decheng Capital
BlackRock
Balyasny Asset Management
Morgan Stanley
GSA Capital Partners
PRIMECAP Management Company

View all funds holding Zentalis Pharmaceuticals